Depo-Provera and Increased Risk of Meningioma: FDA-Label Update. Written by: Anna Ryabets-Lienhard, DO as part of Drugs and Therapeutics Committee In December 2025, the U.S. Food and…
There has been a recall on a small subset of FreeStyle Libre 3 sensors in the U.S. Patients can go to the website http://www.freestyleconfirm.com to get…
Novo Nordisk announced on 11/8/2023 that their long-acting insulin, Levemir®, will be phased out from United States markers completely discontinuing by December 2024. It cited manufacturing constraints,…
FDA recall warning: April 6, 2023 Abbott pharmaceuticals has issued a warning impacting four million readers for glucose monitors after reports that devices were overheating and…
IBSA Pharma Inc. has announced a voluntary recall of 27 lots of TIROSINT®-SOL (levothyroxine sodium) Oral Solution due to concern for subpotency. Company testing revealed a…
FDA notice on sitagliptin contamination The Food and Drug Administration (FDA) recently reported the detection of a nitrosamine impurity (Nitroso-STG-19, known as NTTP) in samples of…
This content is for PES Members.
Not a member yet? Join the largest Pediatric Endocrine community and unlock a host of tools, resources, and enhance your network! Click here to learn more.